$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today

CRISPR Therapeutics CRSP has outperformed the market over the past 5 years by 15.41% on an annualized basis producing an average annual return of 23.37%. Currently, CRISPR Therapeutics has a market capitalization of $3.91 billion.

Buying $100 In CRSP: If an investor had bought $100 of CRSP stock 5 years ago, it would be worth $281.15 today based on a price of $49.91 for CRSP at the time of writing.

CRISPR Therapeutics's Performance Over Last 5 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

CRSP Logo
CRSPCRISPR Therapeutics AG
$41.908.63%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
16.40
Growth
Not Available
Quality
Not Available
Value
5.59
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...